These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35785339)

  • 41. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In Vivo Amyloid, Neurodegeneration, and Verbal Learning in Late Middle-Aged Hispanics.
    Tahmi M; Rippon B; Palta P; Sherwood G; Hernandez G; Soto L; Ceballos F; Pardo M; Laing K; Igwe K; He H; Teresi JA; Moreno H; Razlighi Q; Brickman AM; Luchsinger JA
    J Alzheimers Dis; 2021; 82(1):317-325. PubMed ID: 34024821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly.
    Walker LC; Pahnke J; Madauss M; Vogelgesang S; Pahnke A; Herbst EW; Stausske D; Walther R; Kessler C; Warzok RW
    Acta Neuropathol; 2000 Jul; 100(1):36-42. PubMed ID: 10912918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. APOEε4 potentiates amyloid β effects on longitudinal tau pathology.
    Ferrari-Souza JP; Bellaver B; Ferreira PCL; Benedet AL; Povala G; Lussier FZ; Leffa DT; Therriault J; Tissot C; Soares C; Wang YT; Chamoun M; Servaes S; Macedo AC; Vermeiren M; Bezgin G; Kang MS; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Cohen A; Lopez OL; Klunk WE; Soucy JP; Gauthier S; Souza DO; Triana-Baltzer G; Saad ZS; Kolb HC; Karikari TK; Villemagne VL; Tudorascu DL; Ashton NJ; Zetterberg H; Blennow K; Zimmer ER; Rosa-Neto P; Pascoal TA
    Nat Aging; 2023 Oct; 3(10):1210-1218. PubMed ID: 37749258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
    Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
    Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study.
    Buckley RF; O'Donnell A; McGrath ER; Jacobs HIL; Lois C; Satizabal CL; Ghosh S; Rubinstein ZB; Murabito JM; Sperling RA; Johnson KA; Seshadri S; Beiser AS
    Ann Neurol; 2022 Jul; 92(1):11-22. PubMed ID: 35471588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Divergent Network Patterns of Amyloid-β Deposition in Logopenic and Amnestic Alzheimer's Disease Presentations.
    Leyton CE; Cassidy B; Villemagne VL; Jones G; Kwok JB; Rowe CC; Ballard KJ; Piguet O; Hodges JR
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2016 Jan; 1(1):24-31. PubMed ID: 29560892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sex influences the effects of APOE genotype and Alzheimer's diagnosis on neuropathology and memory.
    Duarte-Guterman P; Albert AY; Barha CK; Galea LAM; On Behalf Of The Alzheimer's Disease Neuroimaging Initiative
    Psychoneuroendocrinology; 2021 Jul; 129():105248. PubMed ID: 33962245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The link between C-reactive protein and Alzheimer's disease among Mexican Americans.
    O'Bryant SE; Johnson L; Edwards M; Soares H; Devous MD; Ross S; Rohlfing G; Hall J;
    J Alzheimers Dis; 2013; 34(3):701-6. PubMed ID: 23254637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between APOE genotype, neuropathology and dementia in the older population of England and Wales.
    Nicoll JA; Savva GM; Stewart J; Matthews FE; Brayne C; Ince P;
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):285-94. PubMed ID: 20880354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
    Leuzy A; Binette AP; Vogel JW; Klein G; Borroni E; Tonietto M; Strandberg O; Mattsson-Carlgren N; Palmqvist S; Pontecorvo MJ; Iaccarino L; Stomrud E; Ossenkoppele R; Smith R; Hansson O;
    JAMA Neurol; 2023 Jun; 80(6):614-623. PubMed ID: 37155176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using Fractional Anisotropy Imaging to Detect Mild Cognitive Impairment and Alzheimer's Disease among Mexican Americans and Non-Hispanic Whites: A HABLE Study.
    Hall JR; Johnson LA; Zhang F; Petersen M; Toga AW; Shi Y; Mason D; Rissman RA; Yaffe K; O'Bryant SE;
    Dement Geriatr Cogn Disord; 2021; 50(3):266-273. PubMed ID: 34569492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.
    Rimajova M; Lenzo NP; Wu JS; Bates KA; Campbell A; Dhaliwal SS; McCarthy M; Rodrigues M; Paton A; Rowe C; Foster JK; Martins RN
    J Alzheimers Dis; 2008 Mar; 13(2):137-46. PubMed ID: 18376055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of Focal Amyloid Deposition Using
    Chung SE; Kim HJ; Jo S; Lee S; Lee Y; Roh JH; Lee JH
    Diagnostics (Basel); 2022 May; 12(6):. PubMed ID: 35741166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults.
    Donovan NJ; Okereke OI; Vannini P; Amariglio RE; Rentz DM; Marshall GA; Johnson KA; Sperling RA
    JAMA Psychiatry; 2016 Dec; 73(12):1230-1237. PubMed ID: 27806159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of cardiovascular risk factors and blood biomarkers with cognition: The HABS-HD study.
    Jiang X; O'Bryant SE; Johnson LA; Rissman RA; Yaffe K;
    Alzheimers Dement (Amst); 2023; 15(1):e12394. PubMed ID: 36911361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease.
    Yin Y; Liu Y; Pan X; Chen R; Li P; Wu HJ; Zhao ZQ; Li YP; Huang LQ; Zhuang JH; Zhao ZX
    PLoS One; 2016; 11(3):e0149945. PubMed ID: 26937653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential Aging Trajectories of Modulation of Activation to Cognitive Challenge in APOE ε4 Groups: Reduced Modulation Predicts Poorer Cognitive Performance.
    Foster CM; Kennedy KM; Rodrigue KM
    J Neurosci; 2017 Jul; 37(29):6894-6901. PubMed ID: 28652414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity.
    Duara R; Loewenstein DA; Lizarraga G; Adjouadi M; Barker WW; Greig-Custo MT; Rosselli M; Penate A; Shea YF; Behar R; Ollarves A; Robayo C; Hanson K; Marsiske M; Burke S; Ertekin-Taner N; Vaillancourt D; De Santi S; Golde T; St D
    Neuroimage Clin; 2019; 22():101800. PubMed ID: 30991618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.